
Angela A. Armstrong
Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2641, 2741, 2654, 2626 |
| Total Applications | 1003 |
| Issued Applications | 675 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 225063
[patent_doc_number] => 07605247
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-10-20
[patent_title] => 'Nucleic acid molecules encoding a wheat sucrose transporter'
[patent_app_type] => utility
[patent_app_number] => 11/901765
[patent_app_country] => US
[patent_app_date] => 2007-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11183
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/605/07605247.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901765
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901765 | Nucleic acid molecules encoding a wheat sucrose transporter | Sep 17, 2007 | Issued |
Array
(
[id] => 4807750
[patent_doc_number] => 20080171328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Screening assays for hedgehog agonists and antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/894601
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 75590
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894601 | Screening assays for hedgehog agonists and antagonists | Aug 19, 2007 | Abandoned |
Array
(
[id] => 5338168
[patent_doc_number] => 20090054632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Hydrophobically-modified protein compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/894745
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 33608
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054632.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894745 | Hydrophobically-modified protein compositions and methods | Aug 19, 2007 | Abandoned |
Array
(
[id] => 4697865
[patent_doc_number] => 20080220049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins'
[patent_app_type] => utility
[patent_app_number] => 11/894045
[patent_app_country] => US
[patent_app_date] => 2007-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 44316
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20080220049.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894045
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894045 | Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins | Aug 16, 2007 | Abandoned |
Array
(
[id] => 8555165
[patent_doc_number] => 08329637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10'
[patent_app_type] => utility
[patent_app_number] => 11/839676
[patent_app_country] => US
[patent_app_date] => 2007-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8100
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11839676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/839676 | Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10 | Aug 15, 2007 | Issued |
Array
(
[id] => 6025793
[patent_doc_number] => 20110053849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'REGULATION OF LITAF MODULATED CYTOKINE PRODUCTION BY A NOVEL P53 SHORT PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/377545
[patent_app_country] => US
[patent_app_date] => 2007-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8199
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377545 | REGULATION OF LITAF MODULATED CYTOKINE PRODUCTION BY A NOVEL P53 SHORT PEPTIDE | Aug 8, 2007 | Abandoned |
Array
(
[id] => 5392156
[patent_doc_number] => 20090209469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass Composition'
[patent_app_type] => utility
[patent_app_number] => 12/374569
[patent_app_country] => US
[patent_app_date] => 2007-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37252
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209469.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374569 | Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass Composition | Aug 5, 2007 | Abandoned |
Array
(
[id] => 4905824
[patent_doc_number] => 20080115238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'HEDGEHOG INHIBITOR ASSAY'
[patent_app_type] => utility
[patent_app_number] => 11/828406
[patent_app_country] => US
[patent_app_date] => 2007-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16647
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20080115238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11828406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/828406 | HEDGEHOG INHIBITOR ASSAY | Jul 25, 2007 | Abandoned |
Array
(
[id] => 8549277
[patent_doc_number] => 08324158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Methods for inhibiting CLC-2 channel with GATX2'
[patent_app_type] => utility
[patent_app_number] => 12/373556
[patent_app_country] => US
[patent_app_date] => 2007-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 22
[patent_no_of_words] => 24399
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373556 | Methods for inhibiting CLC-2 channel with GATX2 | Jul 11, 2007 | Issued |
Array
(
[id] => 5046515
[patent_doc_number] => 20070265189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 11/775642
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 123
[patent_no_of_words] => 48577
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265189.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775642
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775642 | INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS | Jul 9, 2007 | Abandoned |
Array
(
[id] => 5271094
[patent_doc_number] => 20090074870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Alteration of cell membrane for new functions'
[patent_app_type] => utility
[patent_app_number] => 11/819080
[patent_app_country] => US
[patent_app_date] => 2007-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9231
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11819080
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/819080 | Alteration of cell membrane with FasL | Jun 24, 2007 | Issued |
Array
(
[id] => 6219997
[patent_doc_number] => 20100055092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Preventive or Remedy for Inflammatory Disease'
[patent_app_type] => utility
[patent_app_number] => 12/303684
[patent_app_country] => US
[patent_app_date] => 2007-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12858
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12303684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/303684 | Method of treating an inflammatory disease comprising administering an NR 10 antibody antagonist | Jun 7, 2007 | Issued |
Array
(
[id] => 123481
[patent_doc_number] => 07705119
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-04-27
[patent_title] => 'Compositions and methods useful for treating circulatory and hypovolemic shock'
[patent_app_type] => utility
[patent_app_number] => 11/759013
[patent_app_country] => US
[patent_app_date] => 2007-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13483
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705119.pdf
[firstpage_image] =>[orig_patent_app_number] => 11759013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/759013 | Compositions and methods useful for treating circulatory and hypovolemic shock | Jun 5, 2007 | Issued |
Array
(
[id] => 8146692
[patent_doc_number] => 08163699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Method for the treatment of valvular disease'
[patent_app_type] => utility
[patent_app_number] => 12/227872
[patent_app_country] => US
[patent_app_date] => 2007-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10167
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163699.pdf
[firstpage_image] =>[orig_patent_app_number] => 12227872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/227872 | Method for the treatment of valvular disease | May 22, 2007 | Issued |
Array
(
[id] => 4899310
[patent_doc_number] => 20080118924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/752135
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17753
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11752135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/752135 | USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES | May 21, 2007 | Abandoned |
Array
(
[id] => 7740550
[patent_doc_number] => 08106013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-31
[patent_title] => 'ABC transporter ligand GATX1'
[patent_app_type] => utility
[patent_app_number] => 12/299881
[patent_app_country] => US
[patent_app_date] => 2007-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26790
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/106/08106013.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299881 | ABC transporter ligand GATX1 | May 17, 2007 | Issued |
Array
(
[id] => 7509850
[patent_doc_number] => 20110256091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Antibody-Targeted Cytokines for Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/227060
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10053
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256091.pdf
[firstpage_image] =>[orig_patent_app_number] => 12227060
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/227060 | Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis | May 7, 2007 | Issued |
Array
(
[id] => 4693091
[patent_doc_number] => 20080085862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'NATRIURETIC PEPTIDE CONJUGATE USING CARRIER SUBSTANCE'
[patent_app_type] => utility
[patent_app_number] => 11/744162
[patent_app_country] => US
[patent_app_date] => 2007-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5772
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085862.pdf
[firstpage_image] =>[orig_patent_app_number] => 11744162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/744162 | NATRIURETIC PEPTIDE CONJUGATE USING CARRIER SUBSTANCE | May 2, 2007 | Abandoned |
Array
(
[id] => 5374676
[patent_doc_number] => 20090312237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'REGULATING FAT AND CARBOHYDRATE OXIDATION IN MUSCLE TISSUE COMPRISING CONTROLLING GARNITINE CONTENT IN MUSCLE'
[patent_app_type] => utility
[patent_app_number] => 12/295973
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4977
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312237.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295973 | REGULATING FAT AND CARBOHYDRATE OXIDATION IN MUSCLE TISSUE COMPRISING CONTROLLING GARNITINE CONTENT IN MUSCLE | Apr 1, 2007 | Abandoned |
Array
(
[id] => 5397770
[patent_doc_number] => 20090317833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Screening Method'
[patent_app_type] => utility
[patent_app_number] => 12/225721
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19994
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225721 | Screening method for a substance that binds to an intracellular region of TLR4 | Mar 28, 2007 | Issued |